Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment

J Taieb, M Svrcek, R Cohen, D Basile… - European Journal of …, 2022 - Elsevier
Microsatellite unstable (MSI) colorectal cancers (CRCs) are due to DNA mismatch repair
(MMR) deficiency and occurs in15% of non-metastatic diseases and 5% in the metastatic …

Molecular biomarkers for the evaluation of colorectal cancer: guideline from the American Society for Clinical Pathology, College of American Pathologists …

AR Sepulveda, SR Hamilton, CJ Allegra… - American journal of …, 2017 - academic.oup.com
Objectives: To develop evidence-based guideline recommendations through a systematic
review of the literature to establish standard molecular biomarker testing of colorectal cancer …

[HTML][HTML] ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making

HJ Schmoll, E Van Cutsem, A Stein, V Valentini… - Annals of oncology, 2012 - Elsevier
Colorectal cancer (CRC) is the most common tumour type in both sexes combined in
Western countries. Although screening programmes including the implementation of faecal …

The evolving role of microsatellite instability in colorectal cancer: a review

F Gelsomino, M Barbolini, A Spallanzani… - Cancer treatment …, 2016 - Elsevier
Microsatellite instability (MSI) is a molecular marker of a deficient mismatch repair (MMR)
system and occurs in approximately 15% of colorectal cancers (CRCs), more frequently in …

[HTML][HTML] Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention

D Colussi, G Brandi, F Bazzoli… - International journal of …, 2013 - mdpi.com
Research conducted during the past 30 years has increased our understanding of the
mechanisms involved in colorectal cancer initiation and development. The findings have …

Microsatellite instability: diagnosis, heterogeneity, discordance, and clinical impact in colorectal cancer

C Evrard, G Tachon, V Randrian, L Karayan-Tapon… - Cancers, 2019 - mdpi.com
Tumor DNA mismatch repair (MMR) deficiency testing is important to the identification of
Lynch syndrome and decision making regarding adjuvant chemotherapy in stage II …

Identification of Lynch syndrome among patients with colorectal cancer

L Moreira, F Balaguer, N Lindor, A De la Chapelle… - Jama, 2012 - jamanetwork.com
Context Lynch syndrome is the most common form of hereditary colorectal cancer (CRC)
and is caused by germline mutations in DNA mismatch repair (MMR) genes. Identification of …

Pathology and genetics of hereditary colorectal cancer

H Ma, LAA Brosens, GJA Offerhaus, FM Giardiello… - Pathology, 2018 - Elsevier
Colorectal cancer (CRC) accounts for over 8% of all deaths annually worldwide. Between 2
and 5% of all CRCs occur due to inherited syndromes, including Lynch syndrome, familial …

Quantitative Profiling of Colorectal Cancer-Associated Bacteria Reveals Associations between Fusobacterium spp., Enterotoxigenic Bacteroides fragilis (ETBF) and …

KS Viljoen, A Dakshinamurthy, P Goldberg… - PloS one, 2015 - journals.plos.org
Various studies have presented clinical or in vitro evidence linking bacteria to colorectal
cancer, but these bacteria have not previously been concurrently quantified by qPCR in a …

A frameshift peptide neoantigen-based vaccine for mismatch repair-deficient cancers: a phase I/IIa clinical trial

M Kloor, M Reuschenbach, C Pauligk, J Karbach… - Clinical Cancer …, 2020 - AACR
Purpose: DNA mismatch repair (MMR) deficiency is a hallmark of Lynch syndrome, the most
common inherited cancer syndrome. MMR-deficient cancer cells accumulate numerous …
为了回应用户根据美国数字千年版权法案 (DMCA) 向我们提交的投诉,我们已从此页上移除了 1 个结果。如果需要,您可以访问 LumenDatabase.org,查看导致结果遭到移除的 DMCA 投诉内容